Back to Journals » ClinicoEconomics and Outcomes Research » Volume 4

Original Research

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective

       
Total article views   HTML views PDF downloads Totals
12,741 Dovepress* 11,570+ 2,121 13,691
PubMed Central* 1,171 484 1,655
Totals 12,741 2,605 15,346
*Since 23 August 2012
+Since July 2016

View citations on PubMed Central and Google Scholar